Classification of breast cancer patients using somatic mutation profiles and machine learning approaches
暂无分享,去创建一个
[1] Simon C. K. Shiu,et al. Molecular Pattern Discovery Based on Penalized Matrix Decomposition , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[2] I. Tikhonova,et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.
[3] P. Rousseeuw. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis , 1987 .
[4] B. Gusterson. Do 'basal-like' breast cancers really exist? , 2009, Nature Reviews Cancer.
[5] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[6] Adam P. DeLuca,et al. Computational methods for efficient exome sequencing-based genetic testing , 2013 .
[7] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[8] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[9] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Jorge S Reis-Filho,et al. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade , 2010, The Journal of pathology.
[11] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[12] Peilin Jia,et al. Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers , 2013, Genome Medicine.
[13] Pablo Tamayo,et al. Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Batzoglou,et al. Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.
[15] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[16] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[18] Donald L Weaver,et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. , 2009, Archives of pathology & laboratory medicine.
[19] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[20] Ian H. Witten,et al. The WEKA data mining software: an update , 2009, SKDD.
[21] Gottfried Konecny,et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. , 2003, Journal of the National Cancer Institute.
[22] Gabor T. Marth,et al. MOSAIK: A Hash-Based Algorithm for Accurate Next-Generation Sequencing Short-Read Mapping , 2013, PloS one.
[23] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[24] Chittibabu Guda,et al. A Comparison of Variant Calling Pipelines Using Genome in a Bottle as a Reference , 2015, BioMed research international.
[25] L. Murphy,et al. Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[27] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] Ken Chen,et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data , 2012, Bioinform..
[29] Lajos Pusztai,et al. Molecular classification of breast cancer: limitations and potential. , 2006, The oncologist.
[30]
R. Durbin,et al.
Mapping Quality Scores Mapping Short Dna Sequencing Reads and Calling Variants Using P ,
2022
.
[31]
S. Paik,et al.
Development of the 21-gene assay and its application in clinical practice and clinical trials.
,
2008,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32]
R. Tibshirani,et al.
Repeated observation of breast tumor subtypes in independent gene expression data sets
,
2003,
Proceedings of the National Academy of Sciences of the United States of America.
[33]
Jana Marie Schwarz,et al.
MutationTaster evaluates disease-causing potential of sequence alterations
,
2010,
Nature Methods.
[34]
Renaud Gaujoux,et al.
A flexible R package for nonnegative matrix factorization
,
2010,
BMC Bioinformatics.
[35]
B. Stewart,et al.
World cancer report 2014.
,
2014
.
[36]
Mi Kim,et al.
Comprehensive evaluation of matrix factorization methods for the analysis of DNA microarray gene expression data
,
2011,
BMC Bioinformatics.
[37]
Y. Benjamini,et al.
Controlling the false discovery rate: a practical and powerful approach to multiple testing
,
1995
.
[38]
R. Chodankar,et al.
Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells.
,
2012,
Molecular endocrinology.
[39]
E. Boerwinkle,et al.
dbNSFP v2.0: A Database of Human Non‐synonymous SNVs and Their Functional Predictions and Annotations
,
2013,
Human mutation.
[40]
Alex H. Wagner,et al.
Computational methods for identification of disease-associated variations in exome sequencing
,
2014
.
[41]
Michael W. Berry,et al.
Using a literature-based NMF model for discovering gene functional relationships
,
2008,
2008 IEEE International Conference on Bioinformatics and Biomeidcine Workshops.
[42]
Andrew M. Gross,et al.
Network-based stratification of tumor mutations
,
2013,
Nature Methods.
[43]
I. Ellis,et al.
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
,
2007,
Genome Biology.
[44]
R. Tibshirani,et al.
Diagnosis of multiple cancer types by shrunken centroids of gene expression
,
2002,
Proceedings of the National Academy of Sciences of the United States of America.
[45]
Peter E. Hart,et al.
Nearest neighbor pattern classification
,
1967,
IEEE Trans. Inf. Theory.
[46]
Nicholas J. Wang,et al.
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
,
2009,
Cancer research.
[47]
Steven J. M. Jones,et al.
Comprehensive molecular portraits of human breast tumours
,
2013
.
[48]
P. Bork,et al.
A method and server for predicting damaging missense mutations
,
2010,
Nature Methods.
[49]
R. Bast,et al.
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
,
2007,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50]
I. Ellis,et al.
Pathological prognostic factors in breast cancer.
,
1999,
Critical reviews in oncology/hematology.
[51]
H WittenIan,et al.
The WEKA data mining software
,
2009
.
[52]
J. Izbicki,et al.
Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.
,
2011,
Cancer research.
[53]
Steven L. Salzberg,et al.
Book Review: C4.5: Programs for Machine Learning by J. Ross Quinlan. Morgan Kaufmann Publishers, Inc., 1993
,
1994,
Machine Learning.
[54]
Thomas G. Dietterich.
What is machine learning?
,
2020,
Archives of Disease in Childhood.
[55]
Thomas J. Watson,et al.
An empirical study of the naive Bayes classifier
,
2001
.
[56]
Diego Miranda-Saavedra,et al.
TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer
,
2012,
Nature Communications.
[57]
X. Chen,et al.
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
,
2011,
The Journal of clinical investigation.
[58]
L. V. van't Veer,et al.
Clinical application of the 70-gene profile: the MINDACT trial.
,
2008,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59]
Van,et al.
A gene-expression signature as a predictor of survival in breast cancer.
,
2002,
The New England journal of medicine.
[60]
V. Band,et al.
Histological, molecular and functional subtypes of breast cancers
,
2010,
Cancer biology & therapy.
[61]
C. Perou,et al.
Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
,
2008,
Cancer investigation.
[62]
Steven L Salzberg,et al.
Fast gapped-read alignment with Bowtie 2
,
2012,
Nature Methods.
[63]
Yongchao Liu,et al.
CUSHAW3: Sensitive and Accurate Base-Space and Color-Space Short-Read Alignment with Hybrid Seeding
,
2014,
PloS one.
[64]
Yudong D. He,et al.
Gene expression profiling predicts clinical outcome of breast cancer
,
2002,
Nature.
[65]
Gary D Bader,et al.
International network of cancer genome projects
,
2010,
Nature.
[66]
Christian A. Rees,et al.
Molecular portraits of human breast tumours
,
2000,
Nature.
[67]
M. Dunning,et al.
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
,
2014,
Genome Biology.
[68]
C. Caldas,et al.
Triple negative breast cancers: clinical and prognostic implications.
,
2009,
European journal of cancer.
[69]
Heng Li.
Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM
,
2013,
1303.3997.
[70]
M. Tada,et al.
Somatic mutations of the APC gene in primary breast cancers.
,
2000,
The American journal of pathology.
[71]
J. Adams.
Potential for proteasome inhibition in the treatment of cancer.
,
2003,
Drug discovery today.
[72]
J. Platt.
Sequential Minimal Optimization : A Fast Algorithm for Training Support Vector Machines
,
1998
.
[73]
Pablo Cingolani,et al.
© 2012 Landes Bioscience. Do not distribute.
,
2022
.
[74]
Peter T. Simpson,et al.
Molecular classification of breast cancer
,
2014,
Virchows Archiv.
[75]
S. Fox,et al.
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
,
2009,
Nature Medicine.
[76]
Elizabeth M. Smigielski,et al.
dbSNP: the NCBI database of genetic variation
,
2001,
Nucleic Acids Res..
[77]
Qihua Tan,et al.
Classification of Breast Cancer Subtypes by combining Gene Expression and DNA Methylation Data
,
2014,
J. Integr. Bioinform..
[78]
Christopher A. Miller,et al.
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
,
2012,
Genome research.
[79]
Daniel Rios,et al.
Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor
,
2022
.
[80]
Leo Breiman,et al.
Random Forests
,
2001,
Machine Learning.
[81]
Paul Flicek,et al.
Computational approaches to interpreting genomic sequence variation
,
2014,
Genome Medicine.
[82]
E. Boerwinkle,et al.
dbNSFP v3.0: A One‐Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice‐Site SNVs
,
2016,
Human mutation.
[83]
Jason I. Herschkowitz,et al.
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
,
2010,
Breast Cancer Research.
[84]
H. Sebastian Seung,et al.
Algorithms for Non-negative Matrix Factorization
,
2000,
NIPS.
[85]
David M. Kramer,et al.
Biochemistry and Molecular Biology
,
1968,
Nature.
[86]
A. Nobel,et al.
The molecular portraits of breast tumors are conserved across microarray platforms
,
2006,
BMC Genomics.
[87]
B. Kreike,et al.
The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type
,
2010,
The Journal of pathology.
[88]
J. Daling,et al.
Clinical characteristics of different histologic types of breast cancer
,
2005,
British Journal of Cancer.